Literature DB >> 36268251

Hepatocellular carcinoma mutation landscape and its differences between Asians and Whites.

Xingte Chen1, Qiao Ke2, Lei Wang1.   

Abstract

Entities:  

Year:  2022        PMID： 36268251      PMCID： PMC9577991          DOI： 10.21037/hbsn-22-364

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   8.265


× No keyword cloud information.
  9 in total

Review 1.  Molecular therapies and precision medicine for hepatocellular carcinoma.

Authors:  Josep M Llovet; Robert Montal; Daniela Sia; Richard S Finn
Journal:  Nat Rev Clin Oncol       Date:  2018-10       Impact factor: 66.675

2.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

Review 3.  2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights.

Authors:  Di-Yang Xie; Zheng-Gang Ren; Jian Zhou; Jia Fan; Qiang Gao
Journal:  Hepatobiliary Surg Nutr       Date:  2020-08       Impact factor: 7.293

Review 4.  Molecular pathogenesis and systemic therapies for hepatocellular carcinoma.

Authors:  Josep M Llovet; Roser Pinyol; Robin K Kelley; Anthony El-Khoueiry; Helen L Reeves; Xin Wei Wang; Gregory J Gores; Augusto Villanueva
Journal:  Nat Cancer       Date:  2022-04-28

Review 5.  New insights into checkpoint inhibitor immunotherapy and its combined therapies in hepatocellular carcinoma: from mechanisms to clinical trials.

Authors:  Haoer Jin; Sha Qin; Jiang He; Juxiong Xiao; Qingling Li; Yitao Mao; Luqing Zhao
Journal:  Int J Biol Sci       Date:  2022-03-28       Impact factor: 10.750

Review 6.  Therapeutic Management of Advanced Hepatocellular Carcinoma: An Updated Review.

Authors:  Manon Falette Puisieux; Anna Pellat; Antoine Assaf; Claire Ginestet; Catherine Brezault; Marion Dhooge; Philippe Soyer; Romain Coriat
Journal:  Cancers (Basel)       Date:  2022-05-10       Impact factor: 6.575

7.  Mutation profile and its correlation with clinicopathology in Chinese hepatocellular carcinoma patients.

Authors:  Shuo Wang; Huasheng Shi; Tao Liu; Manjiang Li; Sanshun Zhou; Xuan Qiu; Zusen Wang; Weiyu Hu; Weidong Guo; Xiaoqian Chen; Honglin Guo; Xiaoliang Shi; Junping Shi; Yunjin Zang; Jingyu Cao; Liqun Wu
Journal:  Hepatobiliary Surg Nutr       Date:  2021-04       Impact factor: 8.265

Review 8.  Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages.

Authors:  Eva Dazert; Tuyana Boldanova; Charlotte K Y Ng; Mairene Coto-Llerena; Sandro Nuciforo; Caner Ercan; Aleksei Suslov; Marie-Anne Meier; Thomas Bock; Alexander Schmidt; Sylvia Ketterer; Xueya Wang; Stefan Wieland; Matthias S Matter; Marco Colombi; Salvatore Piscuoglio; Luigi M Terracciano; Michael N Hall; Markus H Heim
Journal:  Nat Commun       Date:  2022-05-04       Impact factor: 17.694

Review 9.  Epigenetic remodelling in human hepatocellular carcinoma.

Authors:  Maria Rita Braghini; Oriana Lo Re; Ilaria Romito; Maite G Fernandez-Barrena; Barbara Barbaro; Silvia Pomella; Rossella Rota; Manlio Vinciguerra; Matias A Avila; Anna Alisi
Journal:  J Exp Clin Cancer Res       Date:  2022-03-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.